209 related articles for article (PubMed ID: 17609392)
21. Impact of pneumococcal conjugate vaccine on infections caused by antibiotic-resistant Streptococcus pneumoniae.
Dagan R
Clin Microbiol Infect; 2009 Apr; 15 Suppl 3():16-20. PubMed ID: 19366365
[TBL] [Abstract][Full Text] [Related]
22. Dependence of correlations between antibody titres and opsonophagocytosis on pneumococcal serotype and patient morbidity in pre- and post-pneumococcal vaccination states.
Tarragó D; Aguilar L; Jansen WT; Giménez MJ; Avellón A; Granizo JJ; Casal J
Clin Microbiol Infect; 2007 Apr; 13(4):369-76. PubMed ID: 17359320
[TBL] [Abstract][Full Text] [Related]
23. Immunological responses to pneumococcal vaccine in frail older people.
Ridda I; Macintyre CR; Lindley R; Gao Z; Sullivan JS; Yuan FF; McIntyre PB
Vaccine; 2009 Mar; 27(10):1628-36. PubMed ID: 19100304
[TBL] [Abstract][Full Text] [Related]
24. [Serotype 19F pneumococcal meningitis in an imunocompetent infant immunized with heptavalent pneumococcal conjugated vaccine Prevenar].
Isapof A; Delacourt C; Reinert P; Cohen R; Madhi F
Arch Pediatr; 2009 Aug; 16(8):1133-6. PubMed ID: 19500954
[TBL] [Abstract][Full Text] [Related]
25. Cross-sectional study of nasopharyngeal carriage of Streptococcus pneumoniae in human immunodeficiency virus-infected adults in the conjugate vaccine era.
Onwubiko C; Swiatlo E; McDaniel LS
J Clin Microbiol; 2008 Nov; 46(11):3621-5. PubMed ID: 18845823
[TBL] [Abstract][Full Text] [Related]
26. Distinct approaches to investigate the importance of the murine 4-1BB 4-1BBL interaction in the antibody response to Streptococcus pneumoniae.
Moens L; Jeurissen A; Mittler RS; Wuyts G; Michiels G; Boon L; Ceuppens JL; Bossuyt X
J Leukoc Biol; 2007 Sep; 82(3):638-44. PubMed ID: 17550973
[TBL] [Abstract][Full Text] [Related]
27. The effect of T cell independent and cross-reactive antigen on the immune response to pneumococcal conjugate vaccination.
Rabquer B; Smithson SL; Shriner A; Julie Westerink MA
Immunol Lett; 2006 Aug; 106(2):187-90. PubMed ID: 16781780
[TBL] [Abstract][Full Text] [Related]
28. Full NMR assignment and revised structure for the capsular polysaccharide from Streptococcus pneumoniae type 15B.
Jones C; Lemercinier X
Carbohydr Res; 2005 Feb; 340(3):403-9. PubMed ID: 15680595
[TBL] [Abstract][Full Text] [Related]
29. The 10-valent pneumococcal non-typeable Haemophilus influenzae protein D conjugate vaccine (PHiD-CV) coadministered with DTPw-HBV/Hib and poliovirus vaccines: assessment of immunogenicity.
Bermal N; Szenborn L; Chrobot A; Alberto E; Lommel P; Gatchalian S; Dieussaert I; Schuerman L
Pediatr Infect Dis J; 2009 Apr; 28(4 Suppl):S89-96. PubMed ID: 19325451
[TBL] [Abstract][Full Text] [Related]
30. Development of a DNA microarray to identify the Streptococcus pneumoniae serotypes contained in the 23-valent pneumococcal polysaccharide vaccine and closely related serotypes.
Wang Q; Wang M; Kong F; Gilbert GL; Cao B; Wang L; Feng L
J Microbiol Methods; 2007 Jan; 68(1):128-36. PubMed ID: 16904781
[TBL] [Abstract][Full Text] [Related]
31. A 22-plex chemiluminescent microarray for pneumococcal antibodies.
Pickering JW; Hoopes JD; Groll MC; Romero HK; Wall D; Sant H; Astill ME; Hill HR
Am J Clin Pathol; 2007 Jul; 128(1):23-31. PubMed ID: 17580269
[TBL] [Abstract][Full Text] [Related]
32. Significant variation in serotype-specific immunogenicity of the seven-valent Streptococcus pneumoniae capsular polysaccharide-CRM197 conjugate vaccine occurs despite vigorous T cell help induced by the carrier protein.
Kamboj KK; Kirchner HL; Kimmel R; Greenspan NS; Schreiber JR
J Infect Dis; 2003 May; 187(10):1629-38. PubMed ID: 12721943
[TBL] [Abstract][Full Text] [Related]
33. Functional activity of antibodies after immunization of Finnish and Israeli infants with an 11-valent pneumococcal conjugate vaccine.
Wuorimaa TK; Dagan R; Bailleux F; Haikala R; Ekström N; Eskola J; Yaich M; Käyhty H
Vaccine; 2005 Nov; 23(46-47):5328-32. PubMed ID: 16118028
[TBL] [Abstract][Full Text] [Related]
34. Selective defect of anti-pneumococcal IgG in a patient with persistent polyclonal B cell lymphocytosis.
Hafraoui K; Moutschen M; Smet J; Mascart F; Schaaf-Lafontaine N; Fillet G
Eur J Intern Med; 2009 May; 20(3):e62-5. PubMed ID: 19393481
[TBL] [Abstract][Full Text] [Related]
35. Identification of cross-reactive antibodies with low opsonophagocytic activity for Streptococcus pneumoniae.
Nahm MH; Olander JV; Magyarlaki M
J Infect Dis; 1997 Sep; 176(3):698-703. PubMed ID: 9291318
[TBL] [Abstract][Full Text] [Related]
36. Are the opsonophagocytic activities of antibodies in infant sera measured by different pneumococcal phagocytosis assays comparable?
Väkeväinen M; Jansen W; Saeland E; Jonsdottir I; Snippe H; Verheul A; Käyhty H
Clin Diagn Lab Immunol; 2001 Mar; 8(2):363-9. PubMed ID: 11238223
[TBL] [Abstract][Full Text] [Related]
37. Genetic characteristics of pneumococcal disease in elderly patients before introducing the pneumococcal conjugate vaccine.
Pichon B; Bennett HV; Efstratiou A; Slack MP; George RC
Epidemiol Infect; 2009 Jul; 137(7):1049-56. PubMed ID: 19161642
[TBL] [Abstract][Full Text] [Related]
38. Nature of cross-reactivity between Haemophilus influenzae types a and b and Streptococcus pneumoniae types 6A and 6B.
Lagergård T; Branefors P
Acta Pathol Microbiol Immunol Scand C; 1983 Dec; 91(6):371-6. PubMed ID: 6201038
[TBL] [Abstract][Full Text] [Related]
39. The impact of pneumococcal conjugate vaccines on otitis media-can we extrapolate to pneumonia?
Dagan R
Vaccine; 2008 Jun; 26 Suppl 2():B16-8. PubMed ID: 18793601
[TBL] [Abstract][Full Text] [Related]
40. Purification and structure characterization of the active component in the pneumococcal 22F polysaccharide capsule used for adsorption in pneumococcal enzyme-linked immunosorbent assays.
Skovsted IC; Kerrn MB; Sonne-Hansen J; Sauer LE; Nielsen AK; Konradsen HB; Petersen BO; Nyberg NT; Duus JØ
Vaccine; 2007 Aug; 25(35):6490-500. PubMed ID: 17655983
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
